Company Name: Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. is engaged in the development of therapies for neurological disorders. The company markets FDA-approved therapies and has a developmental pipeline that includes product candidates for a variety of neurological conditions including:
- Parkinson’s disease
- Post-stroke walking difficulties
- Migraine
- Multiple sclerosis
Ticker Symbol: ACOR (NASDAQ)
Company Website: www.acorda.com
Social Media:
Headquarters: Ardsley, NY